The KRW1-on-Injective story is being hyped as “the Korean won going on-chain, with 16 million Korean users about to join.” I looked through the original posts, and I’m going to pour a little cold water on it.
First, this is an MOU. BDACS and Injective signed a memorandum of understanding. Their own post says usage will expand “as South Korea’s regulatory framework develops.” Translation: the law hasn’t given the green light, and nothing is actually up and running yet. But some accounts are already saying it was “tokenized on Injective today.” If you can turn an MOU into a launch, you should go write investor pitch decks.
Second, what does “16 million Koreans have crypto accounts” have to do with KRW1? People are already trading crypto on Upbit with actual Korean won. Why would they take a detour onto an external chain to get a won-backed token that hasn’t even received regulatory approval? User numbers aren’t demand; they’re just a big number pulled out of thin air.
Third, let’s look at what’s actually on-chain. A roundup on X says USDC on Injective is up 43%, to $16.5 million. The growth rate looks nice, but the absolute value is just a medium-sized shitcoin pool. Calling that a “liquidity explosion” is a little embarrassing.
Fourth, dozens of small accounts are taking turns posting the same “What is KRW1? / Why is this significant? / 16M+ Koreans” template, getting anywhere from single-digit to a few hundred views. That’s not consensus; it’s a paid campaign.
I’m not saying won stablecoins have no future. Settlement assets are a real need. But there are only three real signals: Has it been approved by regulators? Can it be redeemed 1:1? How much KRW1 is actually circulating on-chain? None of those boxes are checked yet. Anyone chasing INJ right now is buying a memo.
#INJ #Stablecoins